{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:56:47Z","timestamp":1792065407356,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nrleng.2026.502085","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:02:21Z","timestamp":1777701741000},"page":"502085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of personality traits in response to anti-CGRP monoclonal antibodies in patients with refractory migraine"],"prefix":"10.1016","volume":"41","author":[{"given":"I.","family":"Ros Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"L\u00f3pez Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Recio Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gonz\u00e1lez Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Garc\u00eda Azor\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.L.","family":"Guerrero Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.502085_bib0005","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archneurpsyc.1937.02260160195019","article-title":"Personality features and reactions of subjects with migraine","volume":"37","author":"Wolf","year":"1937","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.nrleng.2026.502085_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-194701000-00001","article-title":"The migrainous personality and constitution: a study of 500 cases","volume":"213","author":"Alvarez","year":"1947","journal-title":"Am J Med"},{"key":"10.1016\/j.nrleng.2026.502085_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.epirev.a036268","article-title":"Migraine headache: epidemiologic perspectives","volume":"6","author":"Linet","year":"1984","journal-title":"Epidemiol Rev"},{"issue":"4","key":"10.1016\/j.nrleng.2026.502085_bib0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1521\/pedi.1990.4.4.362","article-title":"Personality disorders and the five-factor model of personality","volume":"4","author":"Costa","year":"1990","journal-title":"J Pers Disord"},{"issue":"2","key":"10.1016\/j.nrleng.2026.502085_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/bs12020030","article-title":"Migraine and neuroticism: a scoping review","volume":"12","author":"Galvez-S\u00e1nchez","year":"2022","journal-title":"Behav Sci"},{"issue":"9","key":"10.1016\/j.nrleng.2026.502085_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/NMD.0b013e3182a2168a","article-title":"Diagnostic, and statistical manual of mental disorders, 5th edition, and clinical utility","volume":"201","author":"First","year":"2013","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"10.1016\/j.nrleng.2026.502085_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/a0016606","article-title":"An integrative dimensional classification of personality disorder","volume":"21","author":"Widiger","year":"2009","journal-title":"Psychol Assess"},{"key":"10.1016\/j.nrleng.2026.502085_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2020.571035","article-title":"Psychopathological comorbidities and clinical variables in patients with medication overuse headache","volume":"14","author":"Migliore","year":"2020","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-021-01281-z","article-title":"Comorbidities of primary headache disorders: a literature review with meta-analysis","volume":"22","author":"Caponnetto","year":"2021","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/head.13693","article-title":"Association between personality traits and onabotulinumtoxin A response in patients with chronic migraine","volume":"60","author":"Gonzalez-Martinez","year":"2020","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.nrleng.2026.502085_bib0055","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s00415-020-09707-5","article-title":"Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis","volume":"268","author":"Zhao","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.502085_bib0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11916-022-01077-z","article-title":"Real-world patient experience of CGRP-targeting therapy for migraine: a narrative review","volume":"26","author":"Murray","year":"2022","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"10.1016\/j.nrleng.2026.502085_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/ph16070934","article-title":"A scoping review and meta-analysis of anti-CGRP monoclonal antibodies: predicting response","volume":"16","author":"Hong","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nrleng.2026.502085_bib0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia Int J Headache"},{"key":"10.1016\/j.nrleng.2026.502085_bib0075","series-title":"Manual de Pr\u00e1ctica Cl\u00ednica en Cefaleas. Recomendaciones diagn\u00f3stico terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda","first-page":"109","article-title":"Migra\u00f1a cr\u00f3nica","author":"Guerrero Peral","year":"2020"},{"key":"10.1016\/j.nrleng.2026.502085_bib0080","series-title":"Estudio de los rasgos de la personalidad en poblaci\u00f3n normal con el cuestionario Salamanca","author":"Caldero Alonso","year":"2009"},{"key":"10.1016\/j.nrleng.2026.502085_bib0085","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994"},{"key":"10.1016\/j.nrleng.2026.502085_bib0090","series-title":"ICD-10 classifications of mental and behavioural disorder. Clinical descriptions and diagnostic guidelines","year":"1992"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-publhealth-040119-094247","article-title":"Population-based approaches to mental health: history, strategies, and evidence","volume":"41","author":"Purtle","year":"2020","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99803-x","article-title":"Personalized behavior management as a replacement for medications for pain control and mood regulation","volume":"11","author":"Davydov","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2026.502085_bib0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","article-title":"A psychobiological model of temperament and character","volume":"50","author":"Cloninger","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nrleng.2026.502085_bib0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0191-8869(91)90144-Z","article-title":"Dimensions of personality: 16, 5, or 3? Criteria for a taxonomic paradigm","volume":"12","author":"Eysenck","year":"1991","journal-title":"Pers Individ Differ"},{"key":"10.1016\/j.nrleng.2026.502085_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000097971","article-title":"Anger, depression and personality dimensions in patients with migraine without aura","volume":"76","author":"Abbate-Daga","year":"2007","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0120","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-016-0649-2","article-title":"Headache, depression and anxiety: associations in the Eurolight project","volume":"17","author":"Lampl","year":"2016","journal-title":"J Headache Pain"},{"issue":"Suppl. 3","key":"10.1016\/j.nrleng.2026.502085_bib0125","first-page":"S98","article-title":"A review of screening tools for psychiatric comorbidity in headache patients","volume":"46","author":"Maizels","year":"2006","journal-title":"Headache"},{"issue":"12","key":"10.1016\/j.nrleng.2026.502085_bib0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.33588\/rn.5712.2013342","article-title":"Rasgos de la personalidad en pacientes con migra\u00f1a: un estudio multic\u00e9ntrico utilizando el cuestionario de cribado de Salamanca","volume":"57","author":"Mu\u00f1oz","year":"2013","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1468-2982.2000.00010.x","article-title":"Cluster of MMPI personality profiles in chronic tension-type headache and predictable response to fluoxetine","volume":"20","author":"Aguirre","year":"2000","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.nrleng.2026.502085_bib0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jama.2023.0589","article-title":"Borderline personality disorder: a review","volume":"329","author":"Leichsenring","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.nrleng.2026.502085_bib0145","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1007\/s10072-022-06251-0","article-title":"Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention","volume":"43","author":"Lovati","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s10194-021-01342-3","article-title":"Correction to: psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study","volume":"22","author":"Bottiroli","year":"2021","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrleng.2026.502085_bib0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0191-8869(96)00042-6","article-title":"Relationships between Cloninger\u2019s, Zuckerman\u2019s, and Eysenck\u2019s dimensions of personality","volume":"21","author":"Zuckerman","year":"1996","journal-title":"Pers Individ Dif"},{"issue":"7","key":"10.1016\/j.nrleng.2026.502085_bib0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1526-4610.2002.02156.x","article-title":"Borderline personality disorder and the chronic headache patient: review and management recommendations","volume":"42","author":"Saper","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502085_bib0165","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1007\/s10072-022-06190-w","article-title":"Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study","volume":"43","author":"Cetta","year":"2022","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.nrleng.2026.502085_bib0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40263-021-00893-y","article-title":"Long-term effectiveness of three anti-CGRP monoclonal antibodies in resistant chronic migraine patients based on the MIDAS score","volume":"36","author":"Iannone","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-023-01552-x","article-title":"Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.nrleng.2026.502085_bib0180","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-022-01456-2","article-title":"Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation","volume":"23","author":"Lowe","year":"2022","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.nrleng.2026.502085_bib0185","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/head.14194","article-title":"Long\u2010term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high\u2010frequency episodic and chronic migraine in a real world: results of the EARLY 2 study","volume":"61","author":"Barbanti","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502085_bib0190","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-023-01690-2","article-title":"Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry","volume":"24","author":"Obach","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrleng.2026.502085_bib0195","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11916-023-01183-6","article-title":"Potential predictors of response to CGRP monoclonal antibodies in chronic migraine: real-world data","author":"S\u00e1nchez-Rodr\u00edguez","year":"2024","journal-title":"Curr Pain Headache Rep"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:34:30Z","timestamp":1792064070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580826000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2173580826000672"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502085","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of personality traits in response to anti-CGRP monoclonal antibodies in patients with refractory migraine","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2026.502085","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502085"}}